Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

President Bush’s antiregulation bill

Executive Summary

During a campaign stop at the medical device company Stryker in Kalamazoo, Mich. on March 13, the President said he will introduce "reform legislation to correct unreasonable rules we can't change simply through executive action." He says the proposal will be unveiled after expiration of the 90-day regulatory freeze imposed in his Jan. 28 State of the Union address. Bush added that "over-regulation" in the U.S. is a serious threat to the strong competitive position the U.S. medical technology segment now holds in world markets.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS020562

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel